Current Infectious Disease Reports

, Volume 7, Issue 5, pp 357–358 | Cite as

New antimicrobial agents active against Staphylococcus aureus

  • James S. Tan
Clinical Trials Report


Clinical and microbiologic results of this study support, preliminarily, that telavancin is an effective antimicrobial agent for the treatment of infection due to MRSA.


  1. 1.
    Fridkin SK, Hageman JC, Morrison M, et al.: Methicillinresistant Staphylococcus aureus disease in three communities. N Engl J Med 2005, 352:1485–1487.CrossRefGoogle Scholar
  2. 2.
    Miller LG, Perdreau-Remington F, Rieg G, et al.: Necrotizing fasciitis caused by community-associated methicillinresistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005, 352:1445–1453.PubMedCrossRefGoogle Scholar
  3. 3.
    Van BambekeF, Van Laethem Y, Courvalin P, Tulkens PM: Glycopeptide antibiotics. From conventional molecules to new derivatives. Drugs 2004, 64:913–936.PubMedCrossRefGoogle Scholar
  4. 4.
    Raad I, Darouiche R, Vazquez J, et al.: Efficacy and safety of weekly dalbavancin therapy for catheter-related bloodstream infection caused by gram-positive pathogens. Clin Infect Dis 2005, 40:374–380.PubMedCrossRefGoogle Scholar
  5. 5.
    Shaw JP, Seroogy J, Kaniga K, et al.: Pharmacokinetics, serum inhibitory and bactericidal activity, and safety of telavancin in healthy subjects. Antimicrob Agents Chemother 2005, 49:195–201.PubMedCrossRefGoogle Scholar
  6. 6.
    Stryjewski ME, O’Riordan WD, Lau WK, et al.: Telavancin versus standard therapy for treatment of complicated skin and soft tissue infections due to gram-negative bacteria. Clin Infect Dis 2005, 40:1601–1607.PubMedCrossRefGoogle Scholar
  7. 7.
    NathwaniD: Tigecycline: clinical evidence and formulary positioning. International J Antimicrob Agents 2005, 25:185–192.CrossRefGoogle Scholar
  8. 8.
    Yin LY, Lazzarini L, Li F, et al.: Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model. J Antimicrob Chemother 2005, In press.Google Scholar

Copyright information

© Current Science Inc. 2005

Authors and Affiliations

  • James S. Tan

There are no affiliations available

Personalised recommendations